TEMPEST THERAPEUTICS INC (TPST) Institutional Ownership Changes & 13F Activity
TEMPEST THERAPEUTICS INC (TPST). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Versant Venture Management, Llc, Sabby Management, Llc, Renaissance Technologies LLC, Geode Capital Management, Llc, and Blackrock, Inc..
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Sabby Management, Llc | Buy | +178,592 | — | 178,592 | $512.56K | Q4 2025 | Feb 17, 2026 |
| Fmr Llc | Buy | +33,225 | — | 33,225 | $95.36K | Q4 2025 | Feb 17, 2026 |
| Northern Trust Corp | Buy | +14,053 | — | 14,053 | $40.33K | Q4 2025 | Feb 17, 2026 |
| Osaic Holdings, Inc. | Buy | +1,613 | — | 1,613 | $4.62K | Q4 2025 | Feb 17, 2026 |
| Tower Research Capital Llc (Trc) | Buy | +1,325 | — | 1,325 | $3.80K | Q4 2025 | Feb 17, 2026 |
| Jones Financial Companies Lllp | Buy | +239 | — | 239 | $686.00 | Q4 2025 | Feb 17, 2026 |
| Bank Of America Corp | Buy | +37 | — | 37 | $107.00 | Q4 2025 | Feb 17, 2026 |
| Royal Bank Of Canada | Buy | +8 | — | 8 | $0.00 | Q4 2025 | Feb 17, 2026 |
| Morgan Stanley | Buy | +2,058 | — | 2,058 | $5.91K | Q4 2025 | Feb 13, 2026 |
| Versant Venture Management, Llc | Buy | +269,772 | — | 269,772 | $774.25K | Q4 2025 | Feb 12, 2026 |
| Blackrock, Inc. | Buy | +39,068 | — | 39,068 | $112.13K | Q4 2025 | Feb 12, 2026 |
| Dimensional Fund Advisors Lp | Buy | +11,444 | — | 11,444 | $32.84K | Q4 2025 | Feb 12, 2026 |
| Drw Securities, Llc | Buy | +10,447 | — | 10,447 | $29.98K | Q4 2025 | Feb 12, 2026 |
| Federation Des Caisses Desjardins Du Quebec | Buy | +292 | — | 292 | $838.00 | Q4 2025 | Feb 12, 2026 |
| Parallel Advisors, Llc | Buy | +18 | — | 18 | $52.00 | Q4 2025 | Feb 11, 2026 |
| Bnp Paribas Financial Markets | Buy | +3 | — | 3 | $9.00 | Q4 2025 | Feb 10, 2026 |
| Geode Capital Management, Llc | Buy | +44,112 | — | 44,112 | $126.60K | Q4 2025 | Feb 09, 2026 |
| Sbi Securities Co., Ltd. | Buy | +56 | — | 56 | $161.00 | Q4 2025 | Feb 03, 2026 |
| Ubs Group Ag | Buy | +17,542 | — | 17,542 | $50.35K | Q4 2025 | Jan 29, 2026 |
| Renaissance Technologies LLC | Sell | -88,500 | -100.0% | 0 | $0.00 | Q4 2025 | Nov 14, 2023 |
Frequently asked questions about TPST activity
Which institutional owners are buying TPST?
Institutional owners buying TPST include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in TPST activity?
"Buy" means an investor increased their reported position in TPST compared to the prior reporting period. This reflects growing exposure to TEMPEST THERAPEUTICS INC (TPST) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in TPST increasing?
Institutional interest in TPST can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related TPST Institutional Insights
- TPST Overview
- TPST 13F Institutional Holders
- TPST Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- TPST Insider Trading & SEC Form 4 Activity
- TPST Articles
- Top Institutional Investor Stock Rankings